Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-000362
Filing Date
2018-01-02
Accepted
2018-01-02 18:46:31
Documents
2
Period of Report
2018-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2132
2 EX-24 DOCUMENT attachment1.htm EX-24 3053
  Complete submission text file 0001209191-18-000362.txt   6586
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Williams Eddie (Reporting) CIK: 0001725276 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 18503002